RecallRadar

FDA Drug recall D-190-2013

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules,…

On 2013-03-13 the FDA classified a Class III recall of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules,… by Actavis Elizabeth, citing failed Dissolution Specification: This product recall is due to the product lot # 50077231 exceeding dissolution specifications. All other test specifications were met.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-190-2013
ClassificationClass III
Statusterminated
Initiated2013-02-13
Published2013-03-13
Last updated2026-09-13 11:51 UTC
CompanyActavis Elizabeth
DistributionUS

Product

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules, 15 mg, Rx Only, C II, 100 capsules per bottle, MFG. By Actavis Elizabeth LLC. 200 Elmora Ave, Elizabeth, NJ, 07207, USA, NDC 0228-3063-11.

Reason

Failed Dissolution Specification: This product recall is due to the product lot # 50077231 exceeding dissolution specifications. All other test specifications were met.

Identifiers

ndc0228-3062-11
ndc0228-3059-11
ndc0228-3063-11
ndc0228-3060-11
ndc0228-3064-11
ndc0228-3061-11
code_infoLot #: 50077231

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-190-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.